MYX mayne pharma group limited

Just a chart, page-3

  1. 1,478 Posts.
    lightbulb Created with Sketch. 290
    Given the kind of money handed to new management making Mayne virtually debt free (thanks to Metrics sale and selling off Generics ) one would expect there'd be some significant improvement from where we'd fallen to when management first took over , flushed with cash one hell of a head start to get things moving in the right direction , for a while now things seemed to have stalled / plateaued somewhat since then . Can only hope our products perform like we hope they will and have sufficient working capital until they do . Full year trading report is the only real indication as to how well we're being managed , its going to need to be good . Just how many time can we afford to report disappointing results both market investor sentiment and financially .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.25
Change
-0.150(2.78%)
Mkt cap ! $426.5M
Open High Low Value Volume
$5.35 $5.41 $5.19 $1.239M 231.7K

Buyers (Bids)

No. Vol. Price($)
1 1000 $5.17
 

Sellers (Offers)

Price($) Vol. No.
$5.36 1000 1
View Market Depth
Last trade - 16.11pm 25/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.